CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
about
CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activationBinding of manumycin A inhibits IkappaB kinase beta activityThe inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosisNF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cellsTNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activationIdentification of a human NF-kappaB-activating protein, TAB3Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injuryNew insights into the role of nuclear factor-kB in cell growth regulationIL-17 family: cytokines, receptors and signalingStructure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signalingProtein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activityAssociation of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinasesSpecific deficiency in nuclear factor-kappaB activation in neurons of the central nervous systemDoes antigen masking by ubiquitin chains protect from the development of autoimmune diseases?Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceAct1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cellsA protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibodyHsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling.Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitisIL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanismsCIKS/DDX3X interaction controls the stability of the Zc3h12a mRNA induced by IL-17CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelinationA Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1.TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activationCIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatinAdvanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapyThe adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammationInsulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.IL-17F: regulation, signaling and function in inflammation.MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation
P2860
Q24291350-B3AB2647-130D-4B1B-B068-141C37AE7A57Q24297512-9765E03C-1A62-42E2-BDD0-7AF1F87A9777Q24300971-05688F27-3B71-489A-8B6B-561066211957Q24322734-83E44227-713F-466E-BAC5-0DC00C4F1D61Q24534892-439839B3-1929-47CF-B73E-CF5F75C17801Q24541430-6CE19343-4E4B-4F5E-A276-4AE521BE0E7BQ24621651-5D29A0B6-C803-4BC8-9E1E-D1FC6BAD5E60Q24808687-D916F154-5BC2-4219-86BB-A07F8BD2EE7BQ26058119-90786302-2C74-4B18-879B-8D57CA1C51D5Q26860251-62829ED1-2139-41A9-9B0A-90DFE437FC29Q27683721-F0B48215-A1BA-42D3-9808-83E3032DDAA4Q28213409-C24EC538-A78B-4C6D-8D57-58BDC108E826Q28215547-5B86CFCF-1FD9-40CC-A683-8C971B0E7F94Q28216156-44520D85-8D95-4416-B100-3F9500465E61Q28387136-0126128D-797C-403A-8B81-7A7E42C34F48Q28588018-527A82CB-D551-4BAB-BAA8-DB147B2A12F9Q33644666-811DC0CA-5A1A-4C3B-8E96-7083B94A00AFQ33930062-2F82A5CC-D29A-4575-A99C-CD4DBD4483E0Q34082096-BC4BA1D2-94D1-4E90-8B1C-8CBF38506EC1Q34267915-4E1F5DAB-2B67-4339-9D9A-A56E648509F7Q34510989-0987B2BA-6048-403C-8CD4-6732CAE6D68CQ34682122-C01117E1-49A3-487A-8DAA-23399D41BEFEQ34777465-A1DDE75E-61EF-4AE9-AB8B-5AD7A8530838Q34787020-7B3E66AA-F04A-46E8-A80E-CBBE56927271Q35205523-2D2950DA-7546-41C6-B8E0-EBAFCC4494D9Q36016658-FCF756AC-3809-4D93-BC77-D8C478979730Q36142154-19CD833A-56EC-417F-A818-27219CC545F0Q36159216-9ED3D4A3-DF04-489B-A455-7E1054916922Q36277273-34474908-F367-4D93-ACF3-2B6706EB8E7EQ36337179-B6535FE6-7037-44A0-A4A0-3FF4D8CAA2D9Q36711861-2DACBC93-B35F-4511-B021-4EAEEC0BD762Q36885519-EECC11DF-37D9-4F47-A0D7-1045808E9662Q36955377-197340D6-6817-4117-AAE5-26BCF00D164EQ37023176-2CAB5F36-FB84-43E7-83FA-5FA6A7750A56Q37023199-D3E81E8D-560F-479F-9C74-020BC7506245Q37051768-EF827D04-C8F8-495C-ACCC-D0BC6B0671E9Q37070709-8CCA280F-35FB-4EBD-9672-9195809AD3DDQ37230842-974047CE-D4D3-429B-AB2A-85C7AF8617F0Q37398319-87059A24-EB9C-4333-A0A2-33F97E5084D2Q37689443-F9428542-4361-43E9-8227-76D607D08588
P2860
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@ast
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en-gb
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@nl
type
label
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@ast
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en-gb
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@nl
prefLabel
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@ast
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en-gb
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@nl
P2093
P2860
P3181
P356
P1476
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase
@en
P2093
A Leonardi
K Cunningham
U Siebenlist
P2860
P304
P3181
P356
10.1073/PNAS.190245697
P407
P577
2000-09-12T00:00:00Z